Michael Franken, President, Biosimilars Busines at MOMENTA PHARMACEUTICALS INC (MNTA), sold 2,047 shares at $12.29 ($25K) on 2014-12-11, disclosed to the SEC on 2014-12-12.
Scheduled sale ($25k) by President, Biosimilars Busines under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MNTA | SELL | 2015-08-14 | $447K | — | Filing → |
| MNTA | SELL | 2015-06-15 | $11K | — | Filing → |
| MNTA | SELL | 2015-03-13 | $8K | — | Filing → |